Biochemical characteristics of study subjects
| Controls | Cases | ||||||
|---|---|---|---|---|---|---|---|
| Parameters | Male | Female | Total | Male | Female | Total | p Value |
| FBS (mg/dL) | 99.2±7.9 | 95.9±10.1 | 97.6±9.1 | 141.7±43.2 | 138.8±36.4 | 140.4±39.9 | <0.001 |
| PPBS(mg/dL) | 117.5±14.7 | 119.5±19.9 | 118.5±17.4 | 219.4±57.2 | 219.2±63.0 | 219.4±59.6 | <0.001 |
| HbA1c (%) | 5.6±0.4 | 5.4±0.5 | 5.6±0.5 | 7.37±1.2 | 7.3±1.0 | 7.3±1.1 | <0.001 |
| TC (mg/dL) | 181.3±29.3 | 173.9±26.8 | 177.7±28.2 | 214.1±28.5 | 197.0±19.7 | 206.0±26.0* | <0.001 |
| TG (mg/dL) | 142.8±40.8 | 127.2±26.7 | 135.7±35.4* | 188.9±53.6 | 174.1±31.9 | 181.9±45.0 | <0.001 |
| HDL-C (mg/dL) | 48.9±6.5 | 52.5±10.3 | 50.6±8.7 | 46.57±6.6 | 45.63±4.8 | 46.1±5.8 | <0.001 |
| LDL-C (mg/dL) | 102.4±23.4 | 96.6±24.1 | 99.6±23.8 | 129.4±27.7 | 116.6±19.1 | 123.3±24.7* | <0.001 |
| VLDL-C (mg/dl) | 28.6±8.0 | 26.3±6.2 | 27.5±7.3 | 38.0±10.7 | 34.73±6.3 | 36.5±9.0 | <0.001 |
| ADA1 (U/L) | 8.0 ±2.24 | 8.62±2.15 | 8.3±2.21 | 14.19±4.89 | 14.12±4.63 | 14.16 ±4.74 | <0.001 |
| ADA2 (U/L) | 12.29±2.23 | 12.11±2.13 | 12.2 ±2.17 | 21.9±4.42 | 20.95±4.79 | 21.48 ±4.60 | <0.001 |
| Total ADA | 20.2±3.0 | 20.68±3.51 | 20.46 ±3.27 | 36.3±7.37 | 34.63±7.7 | 35.55 ±7.53 | <0.001 |
p<0.05 is significant.
*Significant difference between male and female within controls and case groups, at the level of 0.05.
ADA, adenosine deaminase; FBS, fasting blood sugar; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; PPBS, postprandial blood sugar; TC, total cholesterol; TG, triglyceride; VLDL-C, very low-density lipoprotein cholesterol.